CG
CAPR icon

Cutler Group’s Capricor Therapeutics CAPR Stock Holding History

Cutler Group’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,400
Closed -$1K – 3868
2022
Q4 		$1K Hold
1,400
– – ﹤0.01% 3938
2022
Q3 		$4K Hold
1,400
– – ﹤0.01% 3760
2022
Q2 		$2K Hold
1,400
– – ﹤0.01% 4240
2022
Q1 		$2K Sell
1,400
-1,200
-46% -$4.73K ﹤0.01% 4625
2021
Q4 		$2K Sell
2,600
-600
-19% -$2.1K ﹤0.01% 4676
2021
Q3 		$5K Sell
3,200
-3,200
-50% -$14.6K ﹤0.01% 4417
2021
Q2 		$5K Buy
6,400
+4,400
+220% +$18.6K ﹤0.01% 4402
2021
Q1 		$3K Sell
2,000
-22,600
-92% -$130K ﹤0.01% 4653
2020
Q4 		$8K Buy
24,600
+22,300
+970% +$96.7K ﹤0.01% 3322
2020
Q3 		$1K Buy
+2,300
New +$13.4K ﹤0.01% 4267

Other funds holding CAPR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cutler Group's CAPR Position: Q4 2023 in Review

Cutler Group sold out of Capricor Therapeutics (CAPR) in Q4 2023, closing a stake of 1,000 shares — an estimated $3K sold.

Cutler Group first reported a position in CAPR in Q3 2020 and held it in 13 quarters. The position peaked at $57K in Q3 2021. 37 funds tracked by Wall St. Rank hold CAPR as of Q4 2023.

  • Cutler Group reported no remaining Capricor Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Cutler Group sold 1,000 Capricor Therapeutics shares in Q4 2023, an estimated $3K.
  • Cutler Group first reported a position in Capricor Therapeutics in Q3 2020 and held it in 13 quarters.
  • Cutler Group's Capricor Therapeutics position peaked at $57K in Q3 2021.
  • 37 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.